2 massive drugmakers are locked in a battle over the market for cancer immunotherapy — Goldman analysts say one is pulling ahead

  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 51%

Belgique Nouvelles Nouvelles

Belgique Dernières Nouvelles,Belgique Actualités

Pharma giants Merck and Bristol-Myers Squibb are fighting for dominance in the multi-billion dollar cancer immunotherapy market.

 

Merci pour votre commentaire. Votre commentaire sera publié après examen.

Behind pay wall.. nice trick

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

 /  🏆 729. in BE

Belgique Dernières Nouvelles, Belgique Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Marijuana stocks to watch: Meet the drugmaker making cannabis-based medicines for autism, cancer and moreDrugmakers commonly make their medicines synthetically — think a lab, not a greenhouse. But because its medications employ cannabinoids, the U.K.-based GW Pharma also grows it own cannabis plants.
La source: MarketWatch - 🏆 3. / 97 Lire la suite »

Pharma Industry Pushes Back Against Required Listing of Drug Prices in TV AdsThe pharmaceutical industry is signaling resistance to a Trump administration plan to require that the list price be included for most drugs in television ads, setting the stage for a protracted fight over a proposal with broad bipartisan support. JUST MAKE IT LAW, THEY HAVE THE MONEY. What could be wrong with this? Pharma, why are you upset with telling consumers how much you are going to cost? Is it that you are worried that we will be pissed off with price gouging like the Epi-pen CEO did? Truth in advertising, what a concept!
La source: WSJ - 🏆 98. / 63 Lire la suite »